Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy

Abstract

Given the crucial role of chronic inflammatory signalling and the emerging involvement of autoimmune responses in COPD, therapeutic targeting of the immunoproteasome might represent a novel therapeutic concept for COPD.